Giving esketamine through an IV can quickly and lastingly lift depression in adults who haven’t responded to other treatments.
Claim Language
Language Strength
association
Uses association language (linked to, correlated with)
The claim uses the phrase 'is associated with,' which indicates a statistical or observational link rather than a direct cause-and-effect relationship, placing it in the 'association' category.
Context Details
Domain
medicine
Population
human
Subject
Intravenous esketamine
Action
is associated with
Target
rapid-acting and sustained antidepressant effects in adults with treatment-resistant or refractory major depressive disorder
Intervention Details
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Evidence from Studies
Supporting (1)
The study found that when esketamine is given through an IV drip, it quickly and lastingly helps people with severe depression that didn’t respond to other treatments — which is exactly what the claim says.